Black Diamond Therapeutics, Inc vs Pfizer, Inc. — Stock Comparison

BDTX
Black Diamond Therapeutics, Inc
$2.60
▼ 1.89%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Black Diamond Therapeutics, Inc
BDTX8.3/10vs 6.5/10

Q·Score Breakdown

8.3
Bullish
Overall
6.5
Neutral
10
Quality
7.4
9.7
Health
7
6.5
Growth
5.6
6.9
Valuation
6.7
7.9
Sentiment
5.2
BDTX

High-quality business with 23% return on equity and 32% profit margins.

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $9.86 (+279.1%)
7 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

BDTX
PFE
6.7×
Trailing P/E
19.4×
-2.5×
Forward P/E
9.4×
32.0%
Profit Margin
12.4%
100.0%
Gross Margin
75.8%
22.9%
ROE
8.9%
Revenue Growth
-1.2%
Earnings Growth
3.39
Beta
0.39
Price / Book
$149M
Market Cap
$149.8B
$1 – $5
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →